Buy 9 Meters Biopharma Stock | NMTR Stock Price & Latest News | Public.com
NMTR

9 Meters Biopharma

$0.00 (0.00%)Today
    Small Market Cap
    View 9 Meters Biopharma (NMTR) stock trends here

    About NMTR

    9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC. The full company...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.38
    -0.57
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.04

    Actual EPS
    Q1 2021

    Stats

    Market Cap$372,22M
    Volume2,78M
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$2.26
    1 Year Low$0.37
    Open$1.83
    High$1.85
    Low$1.62

    Buy any stock with any amount of money.

    Download the App
    Download the app